> All the big AIM fraud exposés
> 300 articles and podcasts a month
> Hot share tips
> Original investigations by our experienced team
> No ads, no click-bait, no auto-play videos
Tangent Communications (TNG) has today served up its results for the year to 28th February which were marginally ahead of forecasts and have prompted broker Canaccord to reiterate a BUY stance at 9p with a target price of 12.7p: 37% upside.
Some folks get terribly excited about broker research reports. Henry at JP Morgan upgrades his stance from overweight to buy, Goldman’s removes a stock from its Conviction List but still rates it as buy. You know it all means sweet FA. Sorry to market reporters who fill column inches with this stuff but it is meaningless.
Legendary Investments (LEG) has today issued a release headlined “successful placing”. How does it define success? Meanwhile , how I define “talking complete and utter bollocks?”
It’s been a few weeks since I last covered gold. There hasn’t really been much to say. The precious metal has traded in a tight $30 range, since the end of March. Such periods of inaction have been relatively rare over the last decade, but I wonder now if there are increasing signs that pressure is building for a break to the upside.
Following results from Lombard Risk Management (LRM) last week, I have now managed to catch up with CEO John Wisbey.
Commissioned Researcher Edson reckons that it is a Long & Winding Road ahead for GW Pharma (GWP), the company trying to turn pot into medicines. But Edison sees Mr Blue Sky potential for the shares at 342p.
Hello Share Fans: We've just had a beautiful weekend round here. Enough to set up high expectations of a bumper week for the old Footsie.
Fuel cells are already big business in some parts of the world, which is good news for the companies that make and supply them, such as AFC Energy (AFC).
A former leading transport analyst who still retains a very high City profile has this morning launched a blistering attack on Harriet Green the self-publicity addicted CEO of Thomas Cook (TCG). Is this just sexism in the City or is this fair comment. Read on and judge for yourself. Our man writes:
The Board of AstraZeneca (AZN) has today rejected an improved £55 a share bid from Pfizer. The yanks say they will not go hostile but urge Astra shareholders to tell the board to get a grip and accept. They should do exactly that.
We have 25 copies left of our May giveaway of the Technical Analysis book everyone is talking about. Click the link below to take part in this exclusive offer.
Natural resource investment and development company, Obtala (OBT) has updated investors that work on its forestry business “continues to progress well” as further orders continue to be agreed. that is good news for our readers who bought on this share tip.
I think that you must be aware by now that I have major concerns about the way that AIM operates. The way that money is raised is bad enough in that it creates two classes of investors. The amount of shareholders cash spent on share promotion as opposed to creating value is alarming. But my real gripe is that companies appear able to tell outright lies and get away with it.
According to commissioned researcher Edison Full Year results from waste group Shanks (SKS) met forecasts and the shares at 100p offer an immediate 20% upside.
The last reported results from Independent Resources (IRG) were dire and the company admitted that it needed funding within twelve months to be viewed as a going concern. I should cocoa – the maths are dire.
A new feature – our share tip of the week (end) and we kick off with specialist IT recruitment group Interquest (ITQ) at a 119p share price where we target a total return of 25% in one year. And here is why.
I compare and contrast two companies here: Totally (TLY) and Greka Drilling (GDL). The matter is the question of a delay in results.
Healthcare services company Totally plc (TLY) has announced its results for the 2013 calendar year and we have subsequently spoken to CEO Wendy Lawrence.
Moving away from the ‘T’ theme and medical products, this month’s Stock-Ping highlights a UK based computer software company with a cloud based payments system, and, as of December 31 2013, no debt and turning a profit; Netcall Plc (NET).
I published an article on Friday on COMS (COMS) with a factual error. For that I apologise. My conclusion is unchanged but the revised piece follows.
Search ShareProphets |
Stock market news |
Complete Coverage |
Recent Comments |
Site by Everywhen